Rhinomed Limited

Rhinomed Limitedverified

RNO.AX

Price:

$0.04

Market Cap:

$11.47M

Rhinomed Limited engages in the research, development, and commercialization of consumer and medical devices worldwide. It offers wearable nasal technology that improve breathing, sleeping, and maintaining health and diagnose disease. The company's products include Turbine for enhanced breathing in sports; Mute, which helps to breath more and snore less; Pronto, a vapor inhaler to improve airflow and better sleep; and Rhinoswab that is used to collect a nasal swab. It also engages in developing programs in various markets, including sleep and sleep architecture, the impact of sleep and respiratory, function on cognitive issues, obstructive sleep apnea, pain, nausea, respiratory disease, and ...[Read more]

Industry

Medical - Devices

IPO Date

2007-09-21

Stock Exchange

ASX

Ticker

RNO.AX

The PE Ratio as of January 2025 (TTM) for Rhinomed Limited (RNO.AX) is -1.00

According to Rhinomed Limited’s latest financial reports and current stock price. The company's current PE Ratio is -1.00. This represents a change of -37.19% compared to the average of -1.59 of the last 4 quarters.

Rhinomed Limited (RNO.AX) Historical PE Ratio (quarterly & annually)

How has RNO.AX PE Ratio performed in the past?

The mean historical PE Ratio of Rhinomed Limited over the last ten years is -3.30. The current -1.00 PE Ratio has changed 2.93% with respect to the historical average. Over the past ten years (40 quarters), RNO.AX's PE Ratio was at its highest in in the December 2023 quarter at 0. The PE Ratio was at its lowest in in the January 2012 quarter at -20.37.

Quarterly (TTM)
Annual

Average

-3.30

Median

-2.74

Minimum

-5.69

Maximum

-1.57

Rhinomed Limited (RNO.AX) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Rhinomed Limited PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 745.68%

Maximum Annual PE Ratio = -1.57

Minimum Annual Increase = -68.21%

Minimum Annual PE Ratio = -5.69

Quarterly (TTM)
Annual
YearPE RatioChange
2023-1.83-67.81%
2022-5.6924.17%
2021-4.58192.67%
2020-1.57-68.21%
2019-4.935.45%
2018-4.6766.98%
2017-2.8038.91%
2016-2.01-24.79%
2015-2.6818.04%
2014-2.27745.68%

Rhinomed Limited (RNO.AX) Average PE Ratio

How has RNO.AX PE Ratio performed in the past?

The current PE Ratio of Rhinomed Limited (RNO.AX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-4.04

5-year avg

-3.72

10-year avg

-3.30

Rhinomed Limited (RNO.AX) PE Ratio vs. Peers

How is RNO.AX’s PE Ratio compared to its peers?

Rhinomed Limited’s PE Ratio is greater than IDT Australia Limited (-7.15), greater than Botanix Pharmaceuticals Limited (-53.58), greater than Incannex Healthcare Limited (-2.68), less than Zelira Therapeutics Limited (-0.20), greater than Stemcell United Limited (-1.17),

Build a custom stock screener for Rhinomed Limited (RNO.AX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Rhinomed Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Rhinomed Limited (RNO.AX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Rhinomed Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Rhinomed Limited's PE Ratio?

How is the PE Ratio calculated for Rhinomed Limited (RNO.AX)?

What is the highest PE Ratio for Rhinomed Limited (RNO.AX)?

What is the 3-year average PE Ratio for Rhinomed Limited (RNO.AX)?

What is the 5-year average PE Ratio for Rhinomed Limited (RNO.AX)?

How does the current PE Ratio for Rhinomed Limited (RNO.AX) compare to its historical average?